Skip to main content
Veterinary Medicines

Salmosan Vet, 500 mg/g powder for suspension for fish treatment

Authorised
  • Azamethiphos

Product identification

Medicine name:
Salmosan Vet, 500 mg/g powder for suspension for fish treatment
Salmosan Vet 500 mg/g pulver til behandlingssuspensjon til fisk.
Active substance:
  • Azamethiphos
Target species:
  • Atlantic salmon
Route of administration:
  • Water-borne use

Product details

Active substance and strength:
  • Azamethiphos
    500.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for suspension for fish treatment
Withdrawal period by route of administration:
  • Water-borne use
    • Atlantic salmon
      • Fish meat
        10
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AF17
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:
  • Heat-sealed PVA water soluble bag containing 20 g or 100 g of product contained in a sealed polyethylene lined paper sachet. 5 x 20g or 2 x 100 g packages in a box
  • Heat-sealed PVA water soluble bag containing 20 g or 100 g of product contained in a sealed polyethylene lined paper sachet. 2 x 100 g packages in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Benchmark Animal Health Norway AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Freja Transport & Logistics A/S
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 13-9892
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/0011/001
Concerned member states:
  • Iceland
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/07/2024
Download
Norwegian (PDF)
Published on: 31/07/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 2/11/2023
Updated on: 3/11/2023